MedTrace Logo

GnRH Agonist and Antagonists in an Oocyte Donation Program

NCT00505817 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2009-01-12

No results posted yet for this study

Summary

The primary purpose of this study is to evaluate the effect of the two different protocols (long protocol vs antagonist protocol) on oocyte / embryo quality.

Conditions

  • Effect of Two Protocols of Ovarian Stimulation on Oocyte Quality

Interventions

DRUG

Cetrorelix and Leuprolide

Sponsors & Collaborators

  • Instituto Valenciano de Infertilidad, IVI VALENCIA

    lead OTHER

Principal Investigators

  • Marco Melo, MDPhD · Instituto Valenciano de Infertilidad

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
34 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00505817 on ClinicalTrials.gov